Since higher tumor grade and HER2-positive expression are known to be more aggressive and to have a poor prognosis [15, 25], this finding indicates that the high expression of resistin may be closely related to highly invasive breast cancer and a poor prognosis. Here, ERBB2 is linked to breast cancer.